Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/21/2014US20140235558 Pharmaceutical composition having activity of anticancer
08/21/2014US20140235556 Compositions and methods of treating gliomas
08/21/2014US20140235554 Ophthalmic formulation derived from silk protein
08/21/2014US20140235552 Insulin independence among patients with diabetes utilizing a ppi in combination with an immune tolerance agent
08/21/2014US20140235547 In Vivo Synthesis of Elastic Fiber
08/21/2014US20140235540 Androgen and gonadotropin treatment in females
08/21/2014US20140235533 Dihydrofuran derivatives as insecticidal compounds
08/21/2014US20140235528 Inhibiting gs-fdh to modulate no bioactivity
08/21/2014US20140234859 Controlled platelet activation to monitor therapy of adp antagonists
08/21/2014US20140234452 Composition Comprising Retinol, a Precursor or a Reaction Product of it and a Plant Extract from at least one Chamomilla Plant for the Treatment of Cancer
08/21/2014US20140234448 Disinfecting Formulations and Uses Thereof
08/21/2014US20140234444 Method of using a film-shaped preparation comprising oily substances for oral administration
08/21/2014US20140234443 5-ht3 receptor modulators, methods of making, and use thereof
08/21/2014US20140234440 Method for isolating a chemotherapeutic agent resistant cancer cell with stem cell properties
08/21/2014US20140234437 Iron supplement composition
08/21/2014US20140234435 Setting of hardenable bone substitute
08/21/2014US20140234432 Enhancing coagulation or reducing fibrinolysis
08/21/2014US20140234430 Pharmaceutical methods and topical compositions containing acitretin
08/21/2014US20140234421 Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration
08/21/2014US20140234420 Method of Treating Skin Disorders using Nanoscale Delivery Devices and Transdermal Enhancing Compositions
08/21/2014US20140234418 Method for treating intestinal fibrosis
08/21/2014US20140234417 Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1h-quinolin-2-one or a salt thereof
08/21/2014US20140234416 Use of ferric citrate in the treatment of chronic kidney disease patients
08/21/2014US20140234415 Tablet Dosage Forms
08/21/2014US20140234412 Oral compositions
08/21/2014US20140234410 Combination products
08/21/2014US20140234409 Nicotinamide compositions and the therapeutic use thereof
08/21/2014US20140234408 Beverage compositions and other formulations for treating allergies and methods for making the same
08/21/2014US20140234407 Method for Increasing Lactose Tolerance in Mammals Exhibiting Lactose Intolerance
08/21/2014US20140234406 NOVEL NANOPARTICULATE SUSPENSION FOR INCORPORATING FAT-SOLUBLE VITAMINS IN THE TREATMENT OF HAIR THINNING and HAIR LOSS
08/21/2014US20140234405 Insulin independence among patients with diabetes utilizing a ppi in combination with an immune tolerance agent
08/21/2014US20140234402 Intravenous Infusion of Curcumin and a Calcium Channel Blocker
08/21/2014US20140234398 Dissolution of Arterial Plaque
08/21/2014US20140234396 External patches containing etofenamate
08/21/2014US20140234395 Plaster having adjustable occlusion
08/21/2014US20140234394 Benefical contact surfaces for functional objects
08/21/2014US20140234393 Adhesive patch
08/21/2014US20140234392 Physically and chemically stable nicotine-containing particulate material
08/21/2014US20140234390 Sustained drug delivery implant
08/21/2014US20140234389 Sustained drug delivery implant
08/21/2014US20140234375 Compositions and Methods for Eliciting an Immune Response to Escape Mutants of Targeted Therapies
08/21/2014US20140234368 Hypo- and hyper-acetylated meningococcal capsular saccharides
08/21/2014US20140234367 Botanical formulations
08/21/2014US20140234345 Novel anti-cancer isocarbostyril alkaloid conjugates
08/21/2014US20140234333 Compositions and methods for inhibition of the jak pathway
08/21/2014US20140234329 Antibodies against the ectodomain of erbb3 and uses thereof
08/21/2014US20140234324 Methods for treating a tumor using an antibody that specifically binds grp94
08/21/2014US20140234322 Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury
08/21/2014US20140234319 Treatment of heart failure and related conditions
08/21/2014US20140234318 Tumor specific oligosaccharide epitopes and use thereof
08/21/2014US20140234317 Methods for preventing toxic drug-drug interactions in combination therapies comprising anti-erbb3 agents
08/21/2014US20140234310 Compositions and methods for treatment of bacterial and mycobacterial infections
08/21/2014US20140234306 Agent and Method for Reducing Inflammatory Markers
08/21/2014US20140234305 Methods of treatment using bevacizumab
08/21/2014US20140234303 Treatment of neurological conditions
08/21/2014US20140234299 Therapies for chronic renal failure using one or more integrin antagonists
08/21/2014US20140234295 Isoflavonoid compounds and methods for the treatment of cancer
08/21/2014US20140234284 Fast-setting alkoxysilane spray foams
08/21/2014US20140234282 Beta-lactam compounds for treating diabetes
08/21/2014US20140234280 Compositions and Methods for Controlling Infections
08/21/2014US20140234271 Compositions for proliferation of cells and related methods
08/21/2014US20140234270 Treatment wth alphat selective ligands
08/21/2014US20140234261 Parvovirus Cancer Therapy and Combination with Chemotherapy
08/21/2014US20140234254 Heteroaromatic compounds as pi3 kinase modulators and methods of use
08/21/2014US20140234253 Combination Treatments For Hepatitis C
08/21/2014US20140234251 Purine nucleoside analogues for treating flaviviridae including hepatitis c
08/21/2014US20140234232 Oral and Skin Care Compositions Based on a 3,3-Dialkyl-1,1-Biphenyl-2,2-Diol or a 3,3-Dialkenyl-1,1-Biphenyl-2,2-Diol
08/21/2014US20140234229 Pharmaceutical compositions
08/21/2014US20140234228 Effervescent compositions containing n-acetylcysteine
08/21/2014US20140234227 Foam formulations
08/21/2014US20140234225 Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer
08/21/2014US20140234222 Use of tnf alpha inhibitor for treatment of erosive polyarthritis
08/21/2014US20140234211 Supramolecular aggregates containing amphiphilic monomers, chelating agents and peptides for use for drug delivery and as contrast agents
08/21/2014US20140234210 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
08/21/2014US20140234209 Chimeric and humanized anti-histone antibodies
08/21/2014US20140232029 Kit for measuring the thrombin generation in a sample of a patient's blood or plasma
08/21/2014US20140230833 Nicotine delivery product and method for producing it
08/21/2014US20140230812 Compositions comprising salbutamol sulphate
08/21/2014DE50103551C5 Neue tiotropium-haltige inhalationspulver New tiotropium-containing inhalation powder
08/21/2014DE112006004214B4 Modifizierte Palmkernöle Modified palm kernel oils
08/21/2014DE10066235C5 Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens Method and medicament for the inhibition of expression of a given gene
08/20/2014EP2767543A1 Salts of carbamoyl phosphonic acid esters which act as selective inhibitors of human immunodeficiency virus hiv-1 production
08/20/2014EP2767541A1 LPA receptor agonists and antagonists
08/20/2014EP2767539A1 Pseudopolymorphic forms of a HIV protease inhibitor
08/20/2014EP2767538A1 Tetrandrine derivatives with substituted 5-carbon, preparation method and use thereof
08/20/2014EP2767537A1 Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)
08/20/2014EP2767536A1 Isoxazolo-pyridine derivatives
08/20/2014EP2767533A1 Derivative of butylphthalide and preparation method and use thereof
08/20/2014EP2767531A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same
08/20/2014EP2767310A1 Methods Of Reduction Of Interpatient Variability
08/20/2014EP2767292A1 Sustained Local Anesthetic Composition Containing SAIB
08/20/2014EP2767288A2 Imidated biopolymer adhesive and hydrogel
08/20/2014EP2767287A1 Agent for preventing or treating htlv-i associated myelopathy
08/20/2014EP2767286A1 Oral pharmaceutical composition for the treatment of inflammatory gastrointestinal diseases
08/20/2014EP2767285A1 Tablet including 7-[4-(4-benzo[beta]thiophen-4-yl-piperazin-1-yl) butoxy]-1h-quinolin-2-one or salt thereof
08/20/2014EP2767284A1 D-Fagomine for the control of inflammatory processes related to an overactivation of the humoral immune response
08/20/2014EP2767283A1 Therapeutic agent and preventive agent for demyelinating disease
08/20/2014EP2767282A2 Use of glutaryl histamine to treat respiratory tract infections
08/20/2014EP2767281A1 Base powder from the red raspberry rubus idaeus and activated micronized zeolite for attenuating nicotine addiction, method for the preparation thereof and use thereof
08/20/2014EP2767280A1 Anemia of cancer improving / prophylactic agent
1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 7860